Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

14.26
BATS BZX Real-Time Price
As of 10:50am ET
 +0.19 / +1.35%
Today’s Change
7.35
Today|||52-Week Range
14.36
+23.04%
Year-to-Date
McKesson (MCK) Q1 Earnings: Stock Likely to Beat?
Jul 25 / Zacks.com - Paid Partner Content
Synergy Pharma Offers Suitors Lots of Synergy
Jul 22 / TheStreet.com - Paid Partner Content
Synergy Pharma Offers Lots of Synergies
Jul 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close14.07
Today’s open14.06
Day’s range14.00 - 14.36
Volume37,758
Average volume (3 months)1,455,648
Market cap$2.1B
Dividend yield--
Data as of 10:50am ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+28.06%
Earnings growth (this year)+40.31%
Earnings growth (next 5 years)+39.00%
Revenue growth (last year)+95.66%
P/E ratioNM
Price/Sales11.02
Price/Book21.49

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.74+1.40%
GWPHGW Pharmaceuticals P...-0.82-0.88%
RAREUltragenyx Pharmaceu...+2.97+5.48%
IPXLImpax Laboratories I...+0.20+0.65%
Data as of 10:50am ET, 07/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$149.6M
Annual profit (last year)-$142.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Peter M. Hecht
Chief Financial Officer &
SVP-Corporate Strategy
Thomas Graney
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs